[go: up one dir, main page]

BR0014740A - Lantibiótico - Google Patents

Lantibiótico

Info

Publication number
BR0014740A
BR0014740A BR0014740-0A BR0014740A BR0014740A BR 0014740 A BR0014740 A BR 0014740A BR 0014740 A BR0014740 A BR 0014740A BR 0014740 A BR0014740 A BR 0014740A
Authority
BR
Brazil
Prior art keywords
lantibiotic
salivaricin
applications
bacteriocidal
pyogenes
Prior art date
Application number
BR0014740-0A
Other languages
English (en)
Inventor
John Robert Tagg
Karen Patricia Dierksen
Mathew Upton
Original Assignee
Blis Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blis Technologies Ltd filed Critical Blis Technologies Ltd
Publication of BR0014740A publication Critical patent/BR0014740A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Peptides Or Proteins (AREA)
  • Confectionery (AREA)
  • Medicinal Preparation (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"LANTIBIóTICO". A presente invenção proporciona uma proteína antibacteriana, salivaricina B. A salivaricina B é bacteriocida com relação, inter alia, S. pyogenes e, portanto, tom numerosas aplicações terapêuticas. Essas aplicações incluem, mas não estão limitadas, a formação de parte de formulações terapêuticas para uso no tratamento ou prevenção de infecções estreptocóccicas da garganta.
BR0014740-0A 1999-10-12 2000-10-12 Lantibiótico BR0014740A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ50026199 1999-10-12
PCT/NZ2000/000197 WO2001027143A1 (en) 1999-10-12 2000-10-12 Lantibiotic

Publications (1)

Publication Number Publication Date
BR0014740A true BR0014740A (pt) 2002-06-18

Family

ID=19927569

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014740-0A BR0014740A (pt) 1999-10-12 2000-10-12 Lantibiótico

Country Status (15)

Country Link
US (2) US6773912B1 (pt)
EP (1) EP1169340B1 (pt)
JP (1) JP3673497B2 (pt)
AT (1) ATE362481T1 (pt)
AU (1) AU772224B2 (pt)
BR (1) BR0014740A (pt)
CA (1) CA2363713C (pt)
DE (1) DE60034879T8 (pt)
DK (1) DK1169340T3 (pt)
ES (1) ES2286038T3 (pt)
HK (1) HK1039622B (pt)
NO (1) NO326899B1 (pt)
PL (1) PL206441B1 (pt)
RU (1) RU2279481C2 (pt)
WO (1) WO2001027143A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005517439A (ja) * 2002-02-22 2005-06-16 ブリス テクノロジーズ リミテッド 抗菌性組成物
US6861236B2 (en) 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
WO2004072272A1 (en) * 2003-02-14 2004-08-26 Blis Technologies Limited Bacterial compositions
AU2004257553C1 (en) * 2003-07-18 2011-11-10 Blis Technologies Limited Treatment of malodour
WO2005080423A1 (en) * 2004-02-24 2005-09-01 Commonwealth Scientific And Industrial Research Organisation Antifungal peptides
US8415289B2 (en) * 2005-12-13 2013-04-09 The Trustees Of The University Of Pennsylvania Bacterial-derived BLIS for treatment of acne
FR2905268B1 (fr) * 2006-09-01 2009-01-23 Unither Dev Soc Par Actions Si Substitut salivaire
RU2441915C9 (ru) * 2007-08-03 2012-06-20 Сентинелла Фармасьютикалс, Инк. Гены и белки для биосинтеза лантибиотика 107891
GB0921995D0 (en) * 2009-12-17 2010-02-03 Univ Manchester Antimicrobial peptides
ME02448B (me) 2010-04-07 2016-09-20 Dmg Italia Srl Upotreba streptococcus salivarius u liječenju hroničnih infekcija respiratornog trakta
DE102012203547A1 (de) * 2012-03-07 2013-09-12 Robert Bosch Gesellschaft Für Medizinische Forschung Mbh Antimikrobielle Peptide
CA2783414A1 (en) * 2012-07-22 2014-01-22 Integral Medical Inc. Probiotic composition
CN104398537A (zh) * 2014-11-17 2015-03-11 南京灿辰微生物科技有限公司 一种口腔益生菌组合物
CN111227035A (zh) * 2018-11-28 2020-06-05 内蒙古伊利实业集团股份有限公司 一种含益生菌组合物的发酵乳及其制备方法
CN112391305B (zh) * 2019-08-15 2023-01-13 上海交通大学 唾液链球菌f286及其用途
CA3234323A1 (en) * 2021-09-30 2023-04-06 Blis Technologies Limited Probiotic enhancers and uses thereof
WO2025132965A1 (en) 2023-12-21 2025-06-26 Reichardt Elisabeth Formulations and devices comprising lantibiotic-producing bacteria

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925160A (en) * 1974-09-26 1975-12-09 Univ Creighton Method of producing an antibiotic
JPS615022A (ja) * 1984-06-19 1986-01-10 Advance Res & Dev Co Ltd 腸内細菌叢改善剤
SE463349B (sv) 1989-02-15 1990-11-12 Grahn Eva E Farmaceutiskt preparat foer profylax mot och/eller behandling av beta-streptokockinducerad tonsillit
JPH054927A (ja) * 1991-06-28 1993-01-14 Aizo Matsushiro 乳酸菌含有組成物及びその製造方法
US5872001A (en) 1994-04-20 1999-02-16 Uab Research Foundation Lanthionine antibiotic compositions and methods

Also Published As

Publication number Publication date
WO2001027143A1 (en) 2001-04-19
EP1169340A1 (en) 2002-01-09
JP3673497B2 (ja) 2005-07-20
HK1039622A1 (en) 2002-05-03
US20040232205A1 (en) 2004-11-25
AU7973700A (en) 2001-04-23
CA2363713A1 (en) 2001-04-19
EP1169340A4 (en) 2005-06-08
JP2003516123A (ja) 2003-05-13
AU772224B2 (en) 2004-04-22
PL206441B1 (pl) 2010-08-31
DE60034879T8 (de) 2008-07-03
RU2279481C2 (ru) 2006-07-10
DK1169340T3 (da) 2007-09-24
ES2286038T3 (es) 2007-12-01
DE60034879T2 (de) 2008-02-07
PL364771A1 (en) 2004-12-13
DE60034879D1 (en) 2007-06-28
NO20013905D0 (no) 2001-08-10
US6773912B1 (en) 2004-08-10
NO20013905L (no) 2001-10-10
EP1169340B1 (en) 2007-05-16
HK1039622B (en) 2007-10-18
CA2363713C (en) 2007-11-06
ATE362481T1 (de) 2007-06-15
NO326899B1 (no) 2009-03-16

Similar Documents

Publication Publication Date Title
BR0014740A (pt) Lantibiótico
DE69420142D1 (de) Thermoplastische Elastomere Copolymere und diese enthaltendes Haar und Hautflegemittel
CY1110914T1 (el) Δικυκλο-πυραζολες δραστικες ως αναστολεις kinασων, διεργασια για την παρασκευη τους και φαρμακευτικες συνθεσεις που τις περιλαμβανουν
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
DE69421188D1 (de) Thermoplastische und elastomere silikonpfropfcopolymere und diese enthaltende haar- und hautpflegemittel
BR0113822A (pt) Vacina
DE69424546D1 (de) Thermoplastische elastomere copolymere und diese enthaltendes haar- und hautpflegemittel
NO960682D0 (no) Silikonpodede termoplastiske elastomere kopolymerer og hår- og hudpleiepreparater inneholdende slike
NO964966L (no) Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
NO943837L (no) Terapeutisk aktive derivater av 1-naftylpyrazol-3-karboksamider, fremstilling av slike derivater, samt farmasöytiske preparater
WO1997018790A3 (en) Therapeutic and diagnostic agents for the treatment of microbial infections
CA2388910A1 (en) Antimicrobial activity of the first cationic cluster of human lactoferrin
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
WO2000058475A3 (en) Streptococcus pneumoniae antigens
IT1230157B (it) Uso di sucralfato gel umido per il trattamento di ulcere del derma e come veicolo di farmaci ad attivita' topica
ES2181592B1 (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas
BR0115983A (pt) Uso de sarp-1 para o tratamento e/ou prevenção de escleroderma
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
BR0309569A (pt) Vacinas em combinação que incluem polipeptìdeos imunogênicos de fator camp e gapc
BR0012692A (pt) Conjugado de protease, composição de limpeza e composição de tratamento pessoal
DE60003074D1 (de) Fusidinsäure-derivate
DE60322871D1 (de) Thaltende zubereitungen
BR0116373A (pt) Utilização de tienilciclo-hexilamina, produto, e, composições farmacêuticas
BR9611759A (pt) Processo para o tratamento ou prevenção de mucosite oral em um animal, e, composição para administração oral tópica de um peptìdeo antimicrobiano

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]